首頁
Vertos Medical, Inc.

3月 2026Vertos Medical, Inc.的市場佔有率分析

Vertos Medical is a privately held medical device manufacturer that develops, manufactures, and sells surgical instruments to perform minimally invasive procedures intended to treat lumbar spinal stenosis.

健康 > 醫學

域名vertosmed.com

成立年份2005

僱員51 - 200

年度營收$25M - $50M

Vertos Medical, Inc.

Vertos Medical, Inc.（包含公司地區）

vertosmed.com

查看更多網站流量與參與度資訊

Vertos Medical, Inc.截至 3月 2026 的總收入為 25M - 50M

Vertos Medical, Inc. 熱門網域產生的總收入

Vertos Medical, Inc. 熱門網域 3 年內的總收入

Vertos Medical, Inc. 熱門網域的總收入

vertosmed.com25M - 50M

透過銷售情報查看更多內容

Vertos Medical, Inc.的熱門網域總造訪量

了解Vertos Medical, Inc.市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

子公司細目

vertosmed.com10.2K

透過銷售情報查看更多內容

Vertos Medical, Inc.的熱門網域平均造訪時長

分析Vertos Medical, Inc.參與度指標。

過去 3 個月平均造訪時長

子公司細目

vertosmed.com00:01:45

透過銷售情報查看更多內容

Vertos Medical, Inc.的熱門網域平均頁面瀏覽量

了解Vertos Medical, Inc.如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

子公司細目

vertosmed.com1.91

透過銷售情報查看更多內容

Vertos Medical, Inc.按網域劃分的熱門競爭對手

3月 2026的熱門類似網站，依相似度排名

xtantmedical.com公司名Xtant Medical僱員51 - 200總部美國, 蒙大拿, Belgrade年度營收$100M - $200M訪問總量10.1K金融 > 投資

使用的熱門技術Vertos Medical, Inc.

这些是Vertos Medical, Inc.顶级域名使用的行业网站技术

付費廣告 (17)

Google Adsense

小工具 (7)

reCAPTCHA

社群 (5)

Instagram

轉換與分析 (4)

Google Analytics

更多技術

13

檢視所有

新聞與訊號來自Vertos Medical, Inc.

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞Vertos Medical recognized as number 370 fastest-growing company in North America on the 2023 Deloitte Technology Fast 500TM on Nov 8th '23.ALISO VIEJO, Calif., (November 8, 2023) - Vertos Medical today announced it ranked 370 on the Deloitte Technology Fast 500(TM), a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies in North America, now in its 29th year.

新聞Vertos Medical hired Mehrzad Khakpour as Vice President of Research and Development on Nov 21st '22.ALISO VIEJO, Calif. , Aug. 15, 2023 /PRNewswire/ -- Vertos Medical Inc., a leader in the development of innovative, minimally invasive treatments for lumbar spinal stenosis (LSS), announced today that its Vice President of Sales, Stephen E. Paul, has been named chief commercial officer (CCO), and its Vice President of Research and Development, Mehrzad Khakpour, Ph.D., has been named chief technology officer (CTO) for the rapidly growing company.